Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,114.2
-12.0 (-0.38%)

 

  • STI Straits Times Index
    3,114.2
    -12.0 (-0.38%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.2
    -3.4 (-0.21%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,719.6
    -128.9 (-0.48%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,938.1
    -39.2 (-1.32%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,492.7
    40.8 (0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,191.9
    10.9 (0.18%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,060.7
    -17.2 (-0.83%)
    Index delayed 20 minutes
  • XAO XAO
    6,758.4
    -33.1 (-0.49%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 937.3M
  • Value: 879.2M
  • Rise: 114
  • Fall: 160
  • Unch: 558

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
MDR0.002-
Rex Intl0.093+0.005
ThaiBev0.900+0.025
Genting Sing0.915-0.010
Spackman0.016-
YZJ Shipbldg SGD0.940-0.010
Y Ventures0.112+0.001
AEM1.280+0.020
KLW0.003-
Singapore-eDev0.045-0.002

World Indices

World Indices
Name Last Change
Nasdaq 8,089.5 -67.3
HSI 26,719.6 -128.9
HSCEI 10,540.0 -48.1
Jakarta 6,191.9 +10.9
Nikkei 225 22,492.7 +40.8
SSE Comp 2,938.1 -39.2
Shanghai A 3,078.2 -41.1
Shanghai B 263.8 -3.3
PSE Comp 0.0
KOSPI 2,060.7 -17.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

VIVA BIOTECH VIVA BIOTECH
Quotes 15 Minutes Delayed. Updated at 18 Oct 2019 16:08
Last (HKD): 5.100 Change: +0.130 High: 5.280 Remarks: -
Change (%): +2.62 Low: 4.900
Open 5.000 Yesterday's Close 4.970
Buy Price 5.080 Sell Price 5.100
Buy Volume ('000) 60.5 Sell Volume ('000) 107.5
Cumulative Volume ('000) 4,099.5 Cumulative Value 20,891,260
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.06767 Trailing EPS (HKD) e 0.06767 NAV (HKD) b 1.2153
PE a 75.366 Trailing PE f 75.366 Price / NAV b 4.1965
Dividend (HKD) d - Cash In Hand (HKD) g 0.9008 Issued & Paid-up Shares c 1,584,930,000
Dividend Yield (%) d - Price / Cash In Hand g 5.662 Treasury Shares h -
Beta - 75 Daysi 0.748 R-Squared - 75 Days(%)i 9.42 Market Cap (M) 8,083.143
Beta - 500 Daysi 1.339 R-Squared - 500 Days (%)i 13.89 Enterprise Value (M) 6,716.949
Piotroski F Score 5 Exchange Code 1873 Par Value ( USD ) n.a.
52 Weeks Volatility (%) n.a. 6-Month VWAP n.a. Free Float (%) 8.9
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 11 Sep 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 02 May 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference VIVA BIOTECH HKEx 8,083.143 75.366 75.366 4.1965 -
Industry Biotechnology HKEx 50,647.049 13.476 14.280 5.6838 2.696
Local Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Local Peer SINO BIOPHARM HKEx 139,837.724 13.051 13.469 4.1082 0.658
Local Peer WUXI BIO HKEx 102,248.557 136.896 107.021 10.5252 -
Local Peer BEIGENE HKEx 63,074.765 - - 5.1957 -
Local Peer 3SBIO HKEx 35,338.318 23.360 28.433 3.4830 -
Local Peer GENSCRIPT BIO HKEx 30,218.347 181.737 - 8.5216 -
Local Peer FRONTAGE HKEx 10,760.950 122.151 122.142 5.5694 -
Local Peer HAOHAI BIOTEC HKEx 7,386.091 15.043 16.672 1.7390 1.408
Local Peer ASCLETIS-B HKEx 3,496.553 - - 0.9072 -
Local Peer CKLIFE SCIENCES HKEx 3,267.764 12.427 12.410 0.7827 2.941
Local Peer ESSEX BIO-TECH HKEx 3,253.785 14.080 12.431 3.0943 1.121
Local Peer LEE'S PHARM HKEx 2,641.698 6.316 7.986 1.1656 2.644
Other Local Peers BBI LIFE SCI (HKEx), UNI-BIO GROUP (HKEx), CT ENTERPRISE (HKEx), REGENT PACIFIC (HKEx), BIOSINO BIO-TEC (HKEx), EXTRAWELL PHAR (HKEx), HAO WEN HLDGS (HKEx)
Global Peer AMGEN INC NASDAQ 121,571.387 14.483 15.277 11.2628 2.734
Global Peer GILEAD SCIENCES INC NASDAQ 82,205.269 15.070 13.804 3.6348 3.556
Global Peer CSL ASX 113,904.993 42.456 42.456 15.2216 1.057
Global Peer CELGENE CORP NASDAQ 72,964.886 18.034 13.843 7.2595 -
Global Peer ILLUMINA INC NASDAQ 45,487.680 55.070 48.494 10.5004 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 45,297.278 21.607 20.450 8.9344 -
Global Peer BIOGEN INC NASDAQ 40,589.407 9.161 7.667 3.1336 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 32,989.185 13.496 15.943 3.3815 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,077.029 73.028 21.527 4.8614 0.821
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,066.179 284.356 16.546 2.1711 -
Other Global Peers INCYTE CORPORATION (NASDAQ), SEATTLE GENETICS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), REPLIGEN CORP (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), NATERA INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), POLYNOVO LIMITED (ASX), ESPERION THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ANAPTYSBIO INC (NASDAQ), ALECTOR INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), EPIZYME INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), AVITA MEDICAL LTD (ASX), INTREXON CORP (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), OMEROS CORP (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), CYTOKINETICS INC (NASDAQ), MESOBLAST LTD (ASX), ZIOPHARM ONCOLOGY INC (NASDAQ), NEXTCURE INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CORTEXYME INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), TRANSLATE BIO INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), CHEMOCENTRYX INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), SYNTHORX INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), DERMIRA INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), XBIOTECH INC (NASDAQ), MERUS B V (NASDAQ), KADMON HLDGS INC (NYSE), PERSONALIS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), AGENUS INC (NASDAQ), NEXT SCIENCE LTD (ASX), DYNAVAX TECHNOLOGIES CORP (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), SYROS PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), ARDELYX INC (NASDAQ), TELIX PHARMACEUTIC (ASX), RIGEL PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), GERON CORP (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), RESTORBIO INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), MANNKIND CORPORATION (NASDAQ), SERES THERAPEUTICS (NASDAQ), COMPUGEN (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), DPHARMA (Bursa), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), PFENEX INC (NYSE American), SORRENTO THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CHIASMA INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), KAMADA (NASDAQ), ATHERSYS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), AFFIMED N V (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), SYNDAX PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), CUE BIOPHARMA INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), XOMA CORP (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), IMV INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), AVEO PHARMACEUTICALS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), NANOVIRICIDES INC (NYSE American), AVALON GLOBOCARE CORP (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), SESEN BIO INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), PHYLOGICA LIMITED (ASX), APTOSE BIOSCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), NOVAVAX INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), FENNEC PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), CHIMERIX INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), TREVENA INC (NASDAQ), VERASTEM INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ADURO BIOTECH INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), IMMUTEP LTD (ASX), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CEL-SCI CORP (NYSE American), ARAVIVE INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), CURIS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SYNLOGIC INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), SELECTA BIOSCIENCES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), PORT (SET), ORGENESIS INC (NASDAQ), COHBAR INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), EQUILLIUM INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), IMUGENE LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), NEWLINK GENETICS CORP (NASDAQ), VERMILLION INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), IBIO INC (NYSE American), ORTHOCELL LIMITED (ASX), VASCULAR BIOGENICS LTD (NASDAQ), INMUNE BIO INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), IVERIC BIO INC (NASDAQ), BIONOMICS LTD (ASX), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MEMPHASYS LTD (ASX), SAVARA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), BIOTRON (ASX), RHINOMED LIMITED (ASX), ACTINOGEN MEDICAL LTD (ASX), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BIOCARDIA INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ZAFGEN INC (NASDAQ), CONTRAFECT CORP (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SENESTECH INC (NASDAQ), ORAGENICS INC (NYSE American), MICROBOT MEDICAL INC (NASDAQ), OCUGEN INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), KAZIA THERAPEUTICS LIMITED (ASX), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), CO DIAGNOSTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), BIOCEPT INC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), AEVI GENOMIC MEDIC (NASDAQ), ISORAY INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), PATRYS LIMITED (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), IMMURON LIMITED (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), REGENEUS LTD (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ADALTA LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), VAXART INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PRECIPIO INC (NASDAQ), TOCAGEN INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), Suntar Eco-City^ (SGX), DARE BIOSCIENCE INC (NASDAQ), ATYR PHARMA INC (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HEAT BIOLOGICS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), ONCOLYTICS BIOTECH INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), BENITEC BIOPHARMA LTD (ASX), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), CELLMID LIMITED (ASX), TRACON PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), ENDRA LIFE SCIENCES INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ADVAXIS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), BIOXYNE LIMITED (ASX), LIVING CELL TECHNOLOGIES (ASX), ARCA BIOPHARMA INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), MGRC (Bursa), MEDIBIO LIMITED (ASX), ONCONOVA THERAPEUTICS INC (NASDAQ), MEGASUN (Bursa), ANATARA LIFESCIENCES LTD (ASX), XENETIC BIOSCIENCES INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), TROVAGENE INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), TBG DIAGNOSTICS LTD (ASX), OPGEN INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), CCP TECHNOLOGIES LTD (ASX), QT Vascular (SGX), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), NOVITA HEALTHCARE LTD (ASX), SPHERIX INC (NASDAQ), NANOLLOSE LTD (ASX), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), NEURALSTEM INC (NASDAQ), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.610
+13.59 %
10 Days -+0.580
+12.83 %
20 Days -+0.410
+8.74 %
Medium Term Return 3 Months 0.005+0.840
+19.84 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 3.150 - 5.450 Change From 1 Year Low +1.950 % Change From 1 Year Low (%) +61.90
Change From 1 Year High -0.350 % Change From 1 Year High (%) -6.42
2 Years Range 3.150 - 5.450 Change From 2 Years Low +1.950 % Change From 2 Years Low (%) +61.90
Change From 2 Years High -0.350 % Change From 2 Years High (%) -6.42
5 Years Range 3.150 - 5.450 Change From 5 Years Low +1.950 % Change From 5 Years Low (%) +61.90
Change From 5 Years High -0.350 % Change From 5 Years High (%) -6.42
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Viva Biotech Holdings engages in preclinical research and development of innovative drugs. The firm provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide for their preclinical stage innovative drug development. The company was founded by Feng Mao Hua, Chen Cheney Mao and Ying Wu on August 27, 2008 and is headquartered in Shanghai, China.

Historical Price Data

Date Open High Low Close Volume VWAP
18 Oct 2019 5.000 5.280 4.900 5.100 4,099,500 5.0961
17 Oct 2019 5.030 5.200 4.930 4.970 4,429,500 5.0573
16 Oct 2019 4.700 5.050 4.700 5.020 9,239,500 4.9288
15 Oct 2019 4.610 4.710 4.540 4.700 1,869,500 4.6662
14 Oct 2019 4.500 4.710 4.500 4.650 3,665,500 4.6551
11 Oct 2019 4.500 4.590 4.410 4.490 1,209,500 4.4966
10 Oct 2019 4.310 4.550 4.310 4.500 1,882,000 4.4691
09 Oct 2019 4.440 4.500 4.290 4.380 1,248,000 4.3634
08 Oct 2019 4.460 4.700 4.410 4.440 1,199,500 4.6152
04 Oct 2019 4.530 4.680 4.430 4.520 1,080,500 4.5165
03 Oct 2019 4.410 4.580 4.410 4.530 430,500 4.5114
02 Oct 2019 4.450 4.620 4.330 4.510 1,453,000 4.4917
30 Sep 2019 4.610 4.610 4.470 4.490 1,629,000 4.5168
27 Sep 2019 4.410 4.720 4.410 4.580 2,686,500 4.6069
26 Sep 2019 4.310 4.440 4.300 4.430 1,858,500 4.3780
25 Sep 2019 4.580 4.580 4.280 4.290 2,114,500 4.4156
24 Sep 2019 4.500 4.550 4.400 4.550 2,769,500 4.4780
23 Sep 2019 4.740 4.760 4.350 4.450 2,992,500 4.5045
20 Sep 2019 4.720 4.790 4.520 4.690 1,915,000 4.6847
19 Sep 2019 4.730 4.820 4.630 4.660 2,277,500 4.7401
18 Sep 2019 4.530 4.840 4.530 4.730 5,085,500 4.7385
17 Sep 2019 4.520 4.610 4.490 4.540 1,425,000 4.5446
Summary
Current 2 Weeks
(04 Oct 2019 to 18 Oct 2019)
4.530 5.280 4.290 5.100 29,923,000 -
Previous 2 Weeks
(19 Sep 2019 to 03 Oct 2019)
4.730 5.280 4.290 4.530 20,126,500 -
4 Weeks from
(22 Aug 2019 to 18 Sep 2019)
3.720 5.280 3.720 4.730 52,632,033 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.